• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Neurotrope forms Clinical Advisory Board to support Alzheimer's disease program

Neurotrope forms Clinical Advisory Board to support Alzheimer's disease program

January 16, 2015
CenterWatch Staff

Neurotrope has formed its Alzheimer's Disease Clinical Advisory Board (CAB) with the following appointments: Jeffery L. Cummings, M.D., ScD, CCF; Martin R. Farlow, M.D.; Sam Gandy, M.D., Ph.D.; Christina Sampaio, M.D., Ph.D.; and Michael Weiner, M.D.

Charles S. Ramat, president and CEO of Neurotrope, said, "With our company having recently completed dosing patients in our phase IIa bryostatin study for the treatment of Alzheimer's disease, the appointment of our CAB members comes at a pivotal time for Neurotrope. We look forward to the release of data from that study early in 2015 and the assistance from our new CAB members in helping us further the clinical development and eventual commercialization of this important potential treatment for Alzheimer's disease."

Cummings, chairman, is director of Cleveland Clinic Lou Ruvo Center for Brain Health; director of Materials Science and Engineering Center for Alzheimer's Disease Research; and director of the Deane F. Johnson Center for Neurotherapeutics at UCLA.

Farlow is professor and vice chairman of research, dept. of neurology, at Indiana University; associate co-director of the Indiana Alzheimer's Disease Center; and member of the government Alzheimer's task force.

Gandy works at Mount Sinai. Gandy is chair in Alzheimer's research and is a professor of neurology and psychiatry at Mount Sinai. Gandy was director of the Mount Sinai Center for Cognitive Health and NFL Neurological Care, is a former chairman of the National Medical and Scientific Advisory Council of the Alzheimer's Association and is founding director of the Farber Institute of Neurosciences, Jefferson Medical College.

Sampaio is chief medical officer at the Cure Huntington's Disease Initiative Foundation; professor of clinical pharmacology and therapeutics at the University of Lisbon, Portugal; and former member of the Committee of Proprietary Medicinal Products and the Scientific Advice Working Party at the EMA.

Weiner is a professor at UCSF School of Medicine in radiology and biomedical imaging and Principal Investigator of the Alzheimer's Disease Neuroimaging Initiative

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing